Literature DB >> 3463370

Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases.

G Encabo, A Ruibal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463370

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


× No keyword cloud information.
  5 in total

1.  Chronic bronchitis with fungal infection presenting with marked elevation of serum carbohydrate antigen 19-9: a case report.

Authors:  Ping Han; Wei Yan; Yi Luo; Wei Tu; Jia-Yi He; Jing-Mei Liu; Jin Gong; Yun-Wu Wang; Meng-Ke Li; De-An Tian; Huan-Jun Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis.

Authors:  D Basso; C Fabris; M Plebani; G Del Favero; M Muraca; M T Vilei; M P Panozzo; T Meggiato; P Fogar; A Burlina
Journal:  Clin Investig       Date:  1992-01

3.  Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.

Authors:  Y M Deugnier; A F Rabot; D Guyader; R Moirand; B Turlin; E Boucher; P Lebert; P Brissot
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

4.  Pulmonary sequestration presenting with left upper abdominal bloating and marked elevation of serum carbohydrate antigen 19-9: A case report.

Authors:  Ping Han; Yi Luo; Dean Tian; Wei Yan; Jingmei Liu; Ying Chang; Huaping Xie; Wang Wei; Huanjun Huang
Journal:  Oncol Lett       Date:  2014-03-11       Impact factor: 2.967

Review 5.  Fluorescent contrast agents for tumor surgery.

Authors:  Qi Xiao; Tianming Chen; Shilin Chen
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.